Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 13Nausea 6Neoplasms 5Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Melanoma 1Gynecologic Cancer 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Etoposide 19Carboplatin 19Ifosfamide 16Filgrastim 16Peripheral Blood Stem Cell Transplantation 13Paclitaxel 13Cisplatin 12Cyclophosphamide 10Thiotepa 7Therapeutics 5Radiotherapy 5Melphalan 5Busulfan 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Flow Cytometry 4pegfilgrastim 3etoposide phosphate 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Methylprednisolone 3Methods 3Immunologic Techniques 3Granulocyte Colony-Stimulating Factor 3Epirubicin 3Dexamethasone 3Blood Specimen Collection 3Bleomycin 3tremelimumab 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Testicular Neoplasms × fosaprepitant × Clear all
NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Hoosier Cancer Research Network

Phase 2 Completed
65 enrolled 14 charts
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡